Expression of caspase-3 and TRAIL receptors in CD4+ and CD8+ T cells of SLE patients
|Updated:2026-03-12
|
Expression of caspase-3 and TRAIL receptors in CD4+ and CD8+ T cells of SLE patients
Military Medical ResearchIssue 5, Pages: 321-325(2006)
Affiliations:
1. Department of Dermatology Southwest Hospital
2. Third Military Medical University
3. Department of Pathology
4. Nanfang Hospital
5. Southern Medical University
6. ,Guangzhou,510515
Author bio:
Funds:
DOI:
CLC:R593.241
Published:2006
Accepted:
Scan QR Code
[1]游弋,郝飞,邓永键.Expression of caspase-3 and TRAIL receptors in CD4~+ and CD8~+ T cells of SLE patients[J].Journal of Medical Colleges of PLA,2006(05):321-325.
DOI:
[1]游弋,郝飞,邓永键.Expression of caspase-3 and TRAIL receptors in CD4~+ and CD8~+ T cells of SLE patients[J].Journal of Medical Colleges of PLA,2006(05):321-325.DOI:
Expression of caspase-3 and TRAIL receptors in CD4+ and CD8+ T cells of SLE patients
摘要
Abstract
<正>Objective: To study the expression of caspase-3 and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptors in the CD4 + and CD8+ T cells of systemic lupus enythematosus (SLE) patients. Methods: RT-PCR was used to analyze the expression of caspase-3 and TRAIL receptors in CD4+ and CD8+ T cells of SLE patients and normal subjects. Results: The death domain-containing TRAIL-R1/R2 as well as "decoy" TRAIL-R3/R4 were co-expressed in majority of CD4+ and CD8+ T cells in both SLE patients and normal subjects. The CD8+ T cells from SLE patients showed significantly higher expression of caspase-3 and TRAIL-R2 than those from normal subjects
and the expression was correlated with the activity of the disease. Conclusion: The TRAIL-R2 signal pathway might contribute to the apoptosis of T cells in SLE.
关键词
Keywords
references
The trial reading is over, you can activate your VIP account to continue reading.